Amrutanjan Now in T2T

Dear Investor,

NSE in its circular dated 31st December 2014 has announced the following:

"With effect from 2nd January 2015, the equity shares of Amrutanjan Health Care Limited (Symbol: AMRUTANJAN) shall be traded in Series ‘BE’ – Trade for Trade segment till further notice"

To read the circular, please click here

Over the last two months we witnessed very high volumes in Amrutanjan. Delivery volumes on the other hand were low compared to its usual average. Through this move, speculators will be deterred from day-trading in Amrutanjan Healthcare as they would not be able to square-off their positions the same day. This might lead to a significant fall in daily traded volumes. A knee-jerk reaction to this news might lead to correction and volatility in the short-term. These T2T securities are reviewed monthly, as and when they meet certain criteria set by Exchange, they resume trading under normal category.

We suggest any meaningful correction should be used as an opportunity to load more. Our long-term thesis remains the same; STAY PUT.



Privacy policy
Mobile Analytics
Exact weightage will depend on each subscriber’s risk appetite & comfort. However, as a thumb rule, any position size under 3% is little insignificant to move returns at portfolio level whereas beyond 10% it gets riskier from a concentration standpoint. Accordingly, low could indicate 3-4% weightage, medium 5-7% and high 8-10%.
Structural are those portfolio businesses where earnings are relatively stable (less volatility) and further are expected to rise in a steady fashion. Cyclicals are businesses which experience periods of upcycle followed by downcycle and have large variation in their reported earnings based on industry demand and supply. The mix between the two depends on available opportunities and respective valuation of the two pockets.